Breaking News - The Fly

Open Search

HCM

Hutchmed

$

()

Hutchmed, Innovent announce fruquintinib and sintilimab NDA accepted by NMPA

HCM

4/2/2024 - 05:15am

Hutchmed licenses IMG-007 and IMG-004 to Inmagene

HCM

2/2/2024 - 09:02am

Hutchmed announces Inmagene licenses two drug candidates from the company

HCM

2/2/2024 - 05:13am

Hutchmed announces marketing approval of Elunate in Hong Kong

HCM

1/30/2024 - 05:18am

Hutchmed announces NDA acceptance in China for sovleplenib

HCM

1/10/2024 - 19:00pm

Hutchmed announces continued inclusion of Elunate, Sulanda in China NRDL

HCM

12/13/2023 - 05:21am

What You Missed On Wall Street On Friday

NVDA , IRBT , AMZN

…

11/24/2023 - 13:21pm

Hutchmed upgraded to Buy from Hold at Deutsche Bank

HCM

11/24/2023 - 04:56am

Hutchmed announces Takeda submits fruquintinib NDA to Japan MHLW

HCM , TAK

9/29/2023 - 05:35am

Hutchmed receives breakthrough therapy designation in China for Savolitinib

HCM

8/28/2023 - 20:01pm

Hutchmed announces ESLIM-01 trial met primary endpoint

HCM

8/21/2023 - 05:22am

Hutchmed initiated with a Buy at Citi

HCM

8/2/2023 - 06:35am

Fly Intel: Pre-market Movers

APLS , ADBE , SOFI

…

7/31/2023 - 08:57am

Hutchmed sees 2023 oncology/immunology revenues $450M-$550M

HCM

7/31/2023 - 07:49am

Hutchmed reports 1H EPS 19c vs. (19c) last year

HCM

7/31/2023 - 07:46am